Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
April-2023 Volume 25 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
April-2023 Volume 25 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Establishment and effect evaluation of a stress cardiomyopathy mouse model induced by different doses of isoprenaline

  • Authors:
    • Haosheng Wu
    • Hang Su
    • Chao Zhu
    • Shengbing Wu
    • Shuai Cui
    • Meiqi Zhou
  • View Affiliations / Copyright

    Affiliations: Graduate School, Anhui University of Traditional Chinese Medicine, Hefei, Anhui 230000, P.R. China, Research Institute of Acupuncture and Meridian, Anhui University of Chinese Medicine, Hefei, Anhui 230000, P.R. China
    Copyright: © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 166
    |
    Published online on: February 28, 2023
       https://doi.org/10.3892/etm.2023.11865
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The optimum dose of isoprenaline (ISO) required to induce stress cardiomyopathy (SC) in mice is not known. The present study aimed to investigate the dose‑response association and determine the optimum dose of ISO to establish a high‑morbidity/low‑mortality SC mouse model to simulate the clinical symptoms of SC. A total of 72 6‑week‑old wild‑type female mice (C57BL/6) were randomly divided into control mice administered normal saline and mice treated with increasing ISO concentrations (5, 10, 25, 50 and 100 mg/kg ISO intraperitoneal injections daily for 14 consecutive days). All mice were analysed by body weight assessment, open field test (OFT), echocardiography (Echo), electrocardiogram (ECG), assessment of myocardial pathology and quantification of cortisol, brain natriuretic peptide (BNP), cardiac troponin T (cTnT), catecholamine (CA) and C‑reactive protein (CRP). Compared with the control group, the 25 and 50 mg/kg ISO groups exhibited the most prominent weight changes and lower mortality. The open‑field test showed a significant decrease in autonomous activity behaviour in the 25 and 50 mg/kg ISO groups compared with the control group (P<0.05). Echo revealed that the apex of the heart was balloon‑like in the 25 and 50 mg/kg ISO groups, along with prominent left ventricular dyskinesia. ECG showed a significant increase in ST segment amplitude, QT interval and Q amplitude (P<0.05) in the 25 and 50 mg/kg ISO group compared with the control group. Haematoxylin and eosin staining of heart tissue showed a disordered arrangement of myocardial cells, dissolution of myocardial fibres and cytoplasm, notable widening of myocardial cell space, oedema and hyperaemia of the interstitium, whereas heart tissue of the control group was structurally intact. Compared with the control group, the 25 and 50 mg/kg ISO groups exhibited significantly higher levels of cortisol, BNP, cTNT, CA and CRP (P<0.05). A high‑incidence low‑mortality SC model was successfully and stably developed by administration of 25 and 50 mg/kg ISO. Such models may provide a basis for the development of other animal models of SC.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Barbieri L, Galli F, Conconi B, Gregorini T, Lucreziotti S, Mafrici A, Pravettoni G, Sommaruga M and Carugo S: Takotsubo syndrome in COVID-19 era: Is psychological distress the key? J Psychosom Res. 140(110297)2021.PubMed/NCBI View Article : Google Scholar

2 

Pasqualetto MC, Secco E, Nizzetto M, Scevola M, Altafini L, Cester A and Rigo F: Stress cardiomyopathy in COVID-19 disease. Eur J Case Rep Intern Med. 7(001718)2020.PubMed/NCBI View Article : Google Scholar

3 

Desai HD, Sharma K, Jadeja DM, Desai HM and Moliya P: COVID-19 pandemic induced stress cardiomyopathy: A literature review. Int J Cardiol Heart Vasc. 31(100628)2020.PubMed/NCBI View Article : Google Scholar

4 

Jabri A, Kalra A, Kumar A, Alameh A, Adroja S, Bashir H, Nowacki AS, Shah R, Khubber S, Kanaa'N A, et al: Incidence of stress cardiomyopathy during the coronavirus disease 2019 pandemic. JAMA Netw Open. 3(e2014780)2020.PubMed/NCBI View Article : Google Scholar

5 

Shah RM, Shah M, Shah S, Li A and Jauhar S: Takotsubo syndrome and COVID-19: Associations and implications. Curr Probl Cardiol. 46(100763)2021.PubMed/NCBI View Article : Google Scholar

6 

de Chazal HM, Del Buono MG, Keyser-Marcus L, Ma L, Moeller FG, Berrocal D and Abbate A: Stress cardiomyopathy diagnosis and treatment: JACC state-of-the-art review. J Am Coll Cardiol. 72:1955–1971. 2018.PubMed/NCBI View Article : Google Scholar

7 

Rivera AMC, Ruiz-Bailén M and Aguilar LR: Takotsubo cardiomyopathy-a clinical review. Med Sci Monit. 17:RA135–RA157. 2011.PubMed/NCBI View Article : Google Scholar

8 

Rahbar-Karbasdehi E and Rahbar-Karbasdehi F: Clinical challenges of stress cardiomyopathy during coronavirus 2019 epidemic. Cell Mol Biomed Rep. 1:88–90. 2021.

9 

Okura H: Update of takotsubo syndrome in the era of COVID-19. J Cardiol. 77:361–369. 2021.PubMed/NCBI View Article : Google Scholar

10 

Chhabra L: Prognostication in takotsubo syndrome. Rev Cardiovasc Med. 23(110)2022.PubMed/NCBI View Article : Google Scholar

11 

de Gregorio C, Pistelli L, Borgi M, Trio O, Akashi YJ and Andò G: TakoTsubo syndrome: A well-known disease but not everything is clear yet. Rev Cardiovasc Med. 23(184)2022.

12 

Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M, Cammann VL, Sarcon A, Geyer V, Neumann CA, et al: Clinical features and outcomes of takotsubo (stress) cardiomyopathy. N Eng J Med. 373:929–938. 2015.PubMed/NCBI View Article : Google Scholar

13 

Lyon AR, Citro R, Schneider B, Morel O, Ghadri JR, Templin C and Omerovic E: Pathophysiology of Takotsubo syndrome: JACC state-of-the-art review. J Am Coll Cardiol. 77:902–921. 2021.PubMed/NCBI View Article : Google Scholar

14 

Shams Y and Henareh L: Plasma catecholamine levels in patients with takotsubo syndrome: Implications for the pathogenesis of the disease. Int J Cardiol. 181:35–38. 2015.PubMed/NCBI View Article : Google Scholar

15 

Motiejunaite J, Amar L and Vidal-Petiot E: Adrenergic receptors and cardiovascular effects of catecholamines. Ann Endocrinol (Paris). 82:193–197. 2021.PubMed/NCBI View Article : Google Scholar

16 

Kumar A, Pappachan JM and Fernandez CJ: Catecholamine-induced cardiomyopathy: An endocrinologist's perspective. Rev Cardiovasc Med. 22:1215–1228. 2021.PubMed/NCBI View Article : Google Scholar

17 

Lyon AR, Rees PSC, Prasad S, Poole-Wilson PA and Harding SE: Stress (Takotsubo) cardiomyopathy-a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning. Nat Clin Pract Cardiovasc Med. 5:22–29. 2008.PubMed/NCBI View Article : Google Scholar

18 

Redfors B, Ali A, Shao Y, Lundgren J, Gan LM and Omerovic E: Different catecholamines induce different patterns of takotsubo-like cardiac dysfunction in an apparently afterload dependent manner. Int J Cardiol. 174:330–336. 2014.PubMed/NCBI View Article : Google Scholar

19 

Ali A, Redfors B, Lundgren J, Alkhoury J, Oras J, Gan LM and Omerovic E: Effects of pretreatment with cardiostimulants and beta-blockers on isoprenaline-induced takotsubo-like cardiac dysfunction in rats. Int J Cardiol. 281:99–104. 2019.PubMed/NCBI View Article : Google Scholar

20 

Xiang S, Bian Z, Zhou H, Deng W, Zhu J and Tang Q: . Combined utilization of bisoprolol and glutathione attenuates ventricular remodeling of takotsubo cardiomyopathy in mice. Chin J Cardiovasc Med. 20:358–365. 2015.

21 

Ueyama T: Emotional stress-induced Tako-tsubo Cardiomyopathy: animal model and molecular mechanism. Annals of the New York Academy of Sciences. 1018:437–444. 2004.PubMed/NCBI View Article : Google Scholar

22 

Ueyama T, Kasamatsu K, Hano T, Yamamoto K, Tsuruo Y and Nishio I: . Emotional Stress Induces Transient Left Ventricular Hypocontraction in the Rat Via Activation of Cardiac Adrenoceptors A Possible Animal Model of 'Tako-Tsubo' Cardiomyopathy. Circulation Journal. 66:712–713. 2002.PubMed/NCBI View Article : Google Scholar

23 

Murakami M, Niwa H, Kushikata T, Watanabe H, Hirota K, Ono K and Ohba T: Inhalation anesthesia is preferable for recording rat cardiac function using an electrocardiogram. Biol Pharm Bull. 37:834–839. 2014.PubMed/NCBI View Article : Google Scholar

24 

Citro R, Lyon AR, Meimoun P, Omerovic E, Redfors B, Buck T, Lerakis S, Parodi G, Silverio A, Eitel I, et al: Standard and advanced echocardiography in takotsubo (stress) cardiomyopathy: Clinical and prognostic implications. J Am Soc Echocardiogr. 28:57–74. 2015.PubMed/NCBI View Article : Google Scholar

25 

Sharkey SW: Electrocardiogram mimics of acute ST-segment elevation myocardial infarction: Insights from cardiac magnetic resonance imaging in patients with tako-tsubo (stress) cardiomyopathy. J Electrocardiol. 41:621–625. 2008.PubMed/NCBI View Article : Google Scholar

26 

Hau J, Schapiro SJ and Van Hoosier Jr GL: Handbook of laboratory animal science: Animal Models, Volume III. CRC press, 2004.

27 

Rahbar-Karbasdehi E and Rahbar-Karbasdehi F: Clinical challenges of stress cardiomyopathy during coronavirus 2019 epidemic. Cell Mol Biomed Rep. 1:88–90. 2021.

28 

Lyon AR, Bossone E, Schneider B, Sechtem U, Citro R, Underwood SR, Sheppard MN, Figtree GA, Parodi G, Akashi YJ, et al: Current state of knowledge on Takotsubo syndrome: A position statement from the taskforce on takotsubo syndrome of the heart failure association of the european society of cardiology. J Heart Fail. 18:8–27. 2016.PubMed/NCBI View Article : Google Scholar

29 

Akashi YJ, Nef HM and Lyon AR: Epidemiology and pathophysiology of Takotsubo syndrome. Nat Rev Cardiol. 12:387–397. 2015.PubMed/NCBI View Article : Google Scholar

30 

Hurst RT, Prasad A, Askew JW, Sengupta PP and Tajik AJ: Takotsubo cardiomyopathy: A unique cardiomyopathy with variable ventricular morphology. JACC Cardiovasc Imaging. 3:641–649. 2010.PubMed/NCBI View Article : Google Scholar

31 

Wang X, Pei J and Hu X: The brain-heart connection in takotsubo syndrome: The central nervous system, sympathetic nervous system, and catecholamine overload. Cardiol Res Pract. 2020(4150291)2020.PubMed/NCBI View Article : Google Scholar

32 

Xu W, Li XP, Li EZ, Liu YF, Zhao J, Wei LN and Ma L: Protective effects of allicin on ISO-induced rat model of myocardial infarction via JNK signaling pathway. Pharmacology. 105:505–513. 2020.PubMed/NCBI View Article : Google Scholar

33 

Omerovic E, Citro R, Bossone E, Redfors B, Backs J, Bruns B, Ciccarelli M, Couch LS, Dawson D, Grassi G, et al: Pathophysiology of Takotsubo syndrome -a joint scientific statement from the heart failure association takotsubo syndrome study group and myocardial function working group of the european society of cardiology-part 2: Vascular pathophysiology, gender and sex hormones, genetics, chronic cardiovascular problems and clinical implications. Eur J Heart Fail. 24:272–286. 2022.PubMed/NCBI View Article : Google Scholar

34 

Pimple P, Hammadah M, Wilmot K, Ramadan R, Al Mheid I, Levantsevych O, Sullivan S, Garcia EV, Nye J, Shah AJ, et al: Chest pain and mental stress-induced myocardial ischemia: Sex differences. Am J Med. 131:540–547. 2018.PubMed/NCBI View Article : Google Scholar

35 

Rainville JR, Lipuma T and Hodes GE: Translating the transcriptome: Sex differences in the mechanisms of depression and stress. Biol Psychiatry. 91:25–35. 2022.PubMed/NCBI View Article : Google Scholar

36 

Vaccarino V, Sullivan S, Hammadah M, Wilmot K, Al Mheid I, Ramadan R, Elon L, Pimple PM, Garcia EV, Nye J, et al: Mental stress induced-myocardial ischemia in young patients with recent myocardial infarction: Sex differences and mechanisms. Circulation. 137:794–805. 2018.PubMed/NCBI View Article : Google Scholar

37 

Gebhard C: Women and acute coronary syndromes: Still up to no good. Eur Heart J. 38:1066–1068. 2017.PubMed/NCBI View Article : Google Scholar

38 

Liao X, Chang E, Tang X, Watanabe I, Zhang R, Jeong HW, Adams RH and Jain MK: Cardiac macrophages regulate isoproterenol-induced Takotsubo-like cardiomyopathy. JCI Insight. 7(e156236)2022.PubMed/NCBI View Article : Google Scholar

39 

Shao Y, Redfors B, Ståhlman M, Täng MS, Miljanovic A, Möllmann H, Troidl C, Szardien S, Hamm C, Nef H, et al: A mouse model reveals an important role for catecholamine-induced lipotoxicity in the pathogenesis of stress-induced cardiomyopathy. Eur J Heart Fail. 15:9–22. 2013.PubMed/NCBI View Article : Google Scholar

40 

Khurana I, Maxwell S, Royce S, Mathiyalagan P, Karagiannis T, Mazarakis N, Vongsvivut J, Harikrishnan KN, Okabe J, Al-Hasani K, et al: SAHA attenuates Takotsubo-like myocardial injury by targeting an epigenetic Ac/Dc axis. Signal Transduct Target Ther. 6:1–4. 2021.PubMed/NCBI View Article : Google Scholar

41 

Walsh-Wilkinson E, Arsenault M and Couet J: Segmental analysis by speckle-tracking echocardiography of the left ventricle response to isoproterenol in male and female mice. PeerJ. 9(e11085)2021.PubMed/NCBI View Article : Google Scholar

42 

Deng SX and Tian T: An experimental study on the expression of TNF-α in myocardial injury during stress. J Chongqing Medical University. 3:315–317. 2004.(In Chinese).

43 

Wallner M, Duran JM, Koller S, Mohsin S, Lis S, Sharp TE, Berretta RM and Houser SR: Single-dose isoproterenol does not depress cardiac function in mice. Circul Res. 117:A311. 2015.

44 

Ye KJ, Yang J, Liu Z, et al: Evaluation of cardiac electrical activity in mice with isoproterenol-induced stress cardiomyopathy by optical mapping technique. Chin J Geriatr Heart Brain Vessel Dis. 24:412–417. 2022.(In Chinese).

45 

Gould TD, Dao DT and Kovacsics CE: The open field test. Mood And Anxiety Related Phenotypes In Mice. 42:1–20. 2009.

46 

Thippeswamy BS, Mishra B, Veerapur VP and Gupta G: Anxiolytic activity of Nymphaea alba Linn. in mice as experimental models of anxiety. Indian J Pharmacol. 43:50–55. 2011.PubMed/NCBI View Article : Google Scholar

47 

Lipkind D, Sakov A, Kafkafi N, Elmer GI, Benjamini Y and Golani I: New replicable anxiety-related measures of wall vs. center behavior of mice in the open field. J Appl Physiol (1985). 97:347–359. 2004.PubMed/NCBI View Article : Google Scholar

48 

Leren IS, Saberniak J, Haland TF, Edvardsen T and Haugaa KH: Combination of ECG and echocardiography for identification of arrhythmic events in early ARVC. JACC Cardiovasc Imaging. 10:503–513. 2017.PubMed/NCBI View Article : Google Scholar

49 

Mitsuma W, Kodama M, Ito M, Tanaka K, Yanagawa T, Ikarashi N, Sugiura K, Kimura S, Yagihara N, Kashimura T, et al: Serial electrocardiographic findings in women with Takotsubo cardiomyopathy. Am J Cardiol. 100:106–109. 2007.PubMed/NCBI View Article : Google Scholar

50 

Abraham J, Mudd JO, Kapur N, Klein K, Champion HC and Wittstein IS: Stress cardiomyopathy after intravenous administration of catecholamines and beta-receptor agonists. J Am Coll Cardiol. 53:1320–1325. 2009.PubMed/NCBI View Article : Google Scholar

51 

Gianni M, Dentali F, Grandi AM, Sumner G, Hiralal R and Lonn E: Apical ballooning syndrome or takotsubo cardiomyopathy: A systematic review. Eur Heart J. 27:1523–1529. 2006.PubMed/NCBI View Article : Google Scholar

52 

Thakar S, Chandra P, Hollander G and Lichstein E: Electrocardiographic changes in Takotsubo cardiomyopathy. Pacing Clin Electrophysiol. 34:1278–1282. 2011.PubMed/NCBI View Article : Google Scholar

53 

Kodama S, Miyoshi K, Shiga Y, Maruyama S, Sumi S, Tojou H, Yamanouchi Y and Urata H: Takotsubo cardiomyopathy complicated by high-grade atrioventricular block: A report of two cases. Exp Clin Cardiol. 14:e35–e38. 2009.PubMed/NCBI

54 

Bexton RS and Camm AJ: First degree atrioventricular block. Eur Heart J. 5:107–109. 1984.PubMed/NCBI View Article : Google Scholar

55 

Lee M: Time course of functional recovery in takotsubo (stress) cardiomyopathy: A serial speckle tracking echocardiography and electrocardiography study. J Cardiovasc Imaging. 28:50–60. 2020.PubMed/NCBI View Article : Google Scholar

56 

Semelka RC, Tomei E, Wagner S, Mayo J, Caputo G, O'Sullivan M, Parmley WW, Chatterjee K, Wolfe C and Higgins CB: Interstudy reproducibility of dimensional and functional measurements between cine magnetic resonance studies in the morphologically abnormal left ventricle. Am Heart J. 119:1367–1373. 1990.PubMed/NCBI View Article : Google Scholar

57 

Chockalingam A, Xie GY and Dellsperger KC: Echocardiography in stress cardiomyopathy and acute LVOT obstruction. Int J Cardiovasc Imaging. 26:527–535. 2010.PubMed/NCBI View Article : Google Scholar

58 

Santoro F, Stiermaier T, Tarantino N, Guastafierro F, Graf T, Möller C, Di Martino LFM, Thiele H, Di Biase M, Eitel I and Brunetti ND: Impact of persistent ST elevation on outcome in patients with Takotsubo syndrome. Results from the GErman Italian STress Cardiomyopathy (GEIST) registry. Int J Cardiol. 255:140–144. 2018.PubMed/NCBI View Article : Google Scholar

59 

Ross J Jr: Electorcardiographic ST-segment analysis in the characterization of myocardial ischemia and infarction. Circulation. 53:I73–I81. 1976.PubMed/NCBI

60 

Hall C: Essential biochemistry and physiology of (NT-pro) BNP. Eur J Heart Fail. 6:257–260. 2004.PubMed/NCBI View Article : Google Scholar

61 

Vuolteenaho O, Ala-Kopsala M and Ruskoaho H: BNP as a biomarker in heart disease. Adv Clin Chem. 40:1–36. 2005.PubMed/NCBI

62 

Rahbar-Karbasdehi E and Rahbar-Karbasdehi F: Clinical challenges of stress cardiomyopathy during coronavirus 2019 epidemic. Cell Mol Biomed Rep. 1:88–90. 2021.

63 

Glaveckaitė S, Šerpytis P, Pečiūraitė D, Puronaitė R and Valevičienė N: Clinical features and three-year outcomes of Takotsubo (stress) cardiomyopathy: Observational data from one center. Hellenic J Cardiol. 57:428–434. 2016.PubMed/NCBI View Article : Google Scholar

64 

Ahmed KA, Madhavan M and Prasad A: Brain natriuretic peptide in apical ballooning syndrome (Takotsubo/stress cardiomyopathy): Comparison with acute myocardial infarction. Coron Artery Dis. 23:259–264. 2012.PubMed/NCBI View Article : Google Scholar

65 

Randhawa MS, Dhillon AS, Taylor HC, Sun Z and Desai MY: Diagnostic utility of cardiac biomarkers in discriminating Takotsubo cardiomyopathy from acute myocardial infarction. J Card Fail. 20:2–8. 2014.PubMed/NCBI View Article : Google Scholar

66 

Đurić I, Obradović S and Gligić B: Dynamics of electrocardiographic changes, brain-natriuretic peptide and cortisol levels in a patient with stress (takotsubo) cardiomyopathy: A case report. Vojnosanit Pregl. 70:511–515. 2013.PubMed/NCBI View Article : Google Scholar

67 

Madhavan M, Borlaug BA, Lerman A, Rihal CS and Prasad A: Stress hormone and circulating biomarker profile of apical ballooning syndrome (Takotsubo cardiomyopathy): Insights into the clinical significance of B-type natriuretic peptide and troponin levels. Heart. 95:1436–1441. 2009.PubMed/NCBI View Article : Google Scholar

68 

Świątkiewicz I, Magielski P and Kubica J: C-reactive protein as a risk marker for post-infarct heart failure over a multi-year period. Int J Mol Sci. 22(3169)2021.PubMed/NCBI View Article : Google Scholar

69 

Wittstein IS: Stress cardiomyopathy: A syndrome of catecholamine-mediated myocardial stunning? Cell Mol Neurobiol. 32:847–857. 2021.PubMed/NCBI View Article : Google Scholar

70 

Al Houri HN, Jomaa S, Jabra M, Alhouri AN and Latifeh Y: Pathophysiology of stress cardiomyopathy: A comprehensive literature review. Ann Med Surg (Lond). 2022(104671)2022.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wu H, Su H, Zhu C, Wu S, Cui S and Zhou M: Establishment and effect evaluation of a stress cardiomyopathy mouse model induced by different doses of isoprenaline. Exp Ther Med 25: 166, 2023.
APA
Wu, H., Su, H., Zhu, C., Wu, S., Cui, S., & Zhou, M. (2023). Establishment and effect evaluation of a stress cardiomyopathy mouse model induced by different doses of isoprenaline. Experimental and Therapeutic Medicine, 25, 166. https://doi.org/10.3892/etm.2023.11865
MLA
Wu, H., Su, H., Zhu, C., Wu, S., Cui, S., Zhou, M."Establishment and effect evaluation of a stress cardiomyopathy mouse model induced by different doses of isoprenaline". Experimental and Therapeutic Medicine 25.4 (2023): 166.
Chicago
Wu, H., Su, H., Zhu, C., Wu, S., Cui, S., Zhou, M."Establishment and effect evaluation of a stress cardiomyopathy mouse model induced by different doses of isoprenaline". Experimental and Therapeutic Medicine 25, no. 4 (2023): 166. https://doi.org/10.3892/etm.2023.11865
Copy and paste a formatted citation
x
Spandidos Publications style
Wu H, Su H, Zhu C, Wu S, Cui S and Zhou M: Establishment and effect evaluation of a stress cardiomyopathy mouse model induced by different doses of isoprenaline. Exp Ther Med 25: 166, 2023.
APA
Wu, H., Su, H., Zhu, C., Wu, S., Cui, S., & Zhou, M. (2023). Establishment and effect evaluation of a stress cardiomyopathy mouse model induced by different doses of isoprenaline. Experimental and Therapeutic Medicine, 25, 166. https://doi.org/10.3892/etm.2023.11865
MLA
Wu, H., Su, H., Zhu, C., Wu, S., Cui, S., Zhou, M."Establishment and effect evaluation of a stress cardiomyopathy mouse model induced by different doses of isoprenaline". Experimental and Therapeutic Medicine 25.4 (2023): 166.
Chicago
Wu, H., Su, H., Zhu, C., Wu, S., Cui, S., Zhou, M."Establishment and effect evaluation of a stress cardiomyopathy mouse model induced by different doses of isoprenaline". Experimental and Therapeutic Medicine 25, no. 4 (2023): 166. https://doi.org/10.3892/etm.2023.11865
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team